Quantcast
Last updated on April 17, 2014 at 7:54 EDT

Latest German inventions Stories

2012-02-28 21:27:00

NEW CANAAN, Conn., Feb. 28, 2012 /PRNewswire-iReach/ -- Silver Hill Hospital, the nationally recognized psychiatric hospital in New Canaan, CT, announces the opening of the Chronic Pain and Addiction Center, an intensive residential treatment program for patients with pain who have become addicted to opioid medications. Dr. Seddon R. Savage, President of the American Pain Society, is the Medical Director. (Photo: http://photos.prnewswire.com/prnh/20120228/CG61655) According to a 2011 report...

2012-02-28 15:05:00

NASHVILLE, Tenn., Feb. 28, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced it has entered into an exclusive agreement with China's Harbin Gloria Pharmaceuticals Co., Ltd. (SHE: 002437)for the commercialization of Acetadote® (acetylcysteine), its injectable drug used to treat acetaminophen overdose, and Caldolor® (ibuprofen) Injection, which is used to treat pain and fever in the hospital setting. The agreement will provide Harbin Gloria...

2012-02-27 07:30:00

SAN FRANCISCO, Feb. 27, 2012 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced a presentation of positive clinical data for NKTR-181, its new oral opioid analgesic molecule, at the 2012 American Academy of Pain Medicine's 28th Annual Meeting (AAPM). NKTR-181 is a novel mu-opioid agonist molecule, which was designed to have a slow rate of entry into the brain to reduce the attractiveness of the molecule as a target of abuse and to reduce its CNS-mediated side effects....

2012-02-24 17:30:00

PALM SPRINGS, Calif., Feb. 24, 2012 /PRNewswire-USNewswire/ -- Results were presented today from the first study to show that the daily use of long-acting opioids increases the risk of hypogonadism (low testosterone) in men when compared to those taking short-acting opioids. These results were reported today at a poster session at the American Academy of Pain Medicine's 28th Annual Meeting. Although this was a small retrospective study, Dr. Rubinstein believes this higher rate of...

2012-02-24 13:00:00

PALM SPRINGS, Calif., Feb. 24, 2012 /PRNewswire-USNewswire/ -- Research presented today at the American Academy of Pain Medicine's 28th Annual Meeting shows that substance use education incorporated into a cognitive behavioral rehabilitation programming is effective to improve pain and function for the chronic pain patient at high-risk for comorbid substance abuse. The results of the study conducted at Mayo Pain Rehabilitation Center, Rochester, MN, were presented today by Sarah E. Hayes...

2012-02-22 11:36:00

HENDERSONVILLE, Tenn., Feb. 22, 2012 /PRNewswire/ -- Hendersonville Medical Center today announced that anesthesiologist Peter B. Kroll, M.D., has published an article in the January issue of peer-reviewed medical journal Pain Management. The article, titled "Intravenous Ibuprofen for Postoperative Pain," reviews the growing body of research demonstrating the safety and efficacy of Caldolor® (ibuprofen) Injection for the management of surgical pain and purports potential expanded...

2012-02-21 12:29:08

MD Anderson research shows promise for patients suffering from chronic pain By reformulating the common cancer drug imatinib (Gleevec®), researchers have eliminated morphine tolerance in rats — an important step toward improving the effectiveness of chronic pain management in patients, according to researchers at The University of Texas MD Anderson Cancer Center. Narcotics such as morphine are a mainstay of chronic pain treatment. Over time, tolerance to the pain-relieving...

2012-02-17 20:45:00

CAPE CORAL, Fla., Feb. 17, 2012 /PRNewswire-iReach/ -- Fidelitas Medical IT-Solutions, LP announced today the launch of their product DDS, a dispensing and documentation system for methadone treatment. Their mission, according to the company's CEO, Andreas Kunz, is to increase the safety and efficiency of MMT (Methadone Maintenance Treatment) programs in North America. "We have seen that patients are sometimes given inaccurate doses of methadone due to cumbersome documentation...

2012-02-15 08:25:00

SACRAMENTO, California, February 15, 2012 /PRNewswire/ -- It has become common for people with chronic pain who use opioid pain medication to be required to submit to random drug screens as a condition of treatment. The rationale for the use of this billable procedure is to prevent and reduce opioid associated morbidity and mortality. However, there remains insufficient evidence as to the efficacy of drug testing people with chronic pain. A new article entitled...

2012-01-30 13:48:00

BOSTON, Jan. 30, 2012 /PRNewswire/ -- Millennium Laboratories, the leading research based clinical diagnostics company dedicated to improving the lives of people suffering from pain, is proud to be the lead sponsor of the first International Conference on Opioids, June 10-12, 2012 at the Joseph B. Martin Conference Center at Harvard Medical School. The Journal of Opioid Management is offering this unique forum comprised of renowned specialists in basic science, clinical application, and...